Immuno-chemotherapy containing rituximab is associated with improved survival in primary CNS B cell lymphoma

Gareth Peter Gregory, Ashwini Arumugaswamy, Teresa Leung, Kah-Lok Chan, Melody Abikhair, Kipp David, Constantine S Tam, Ashish Bajel, Lawrence Cher, Andrew P Grigg, David S Ritchie, Stephen Opat

Research output: Contribution to conferencePoster

Original languageEnglish
Publication statusPublished - 2012
Event17th Congress of the European Hematology Association - Amsterdam, Netherlands
Duration: 14 Jun 201217 Jun 2012

Conference

Conference17th Congress of the European Hematology Association
CountryNetherlands
CityAmsterdam
Period14/06/1217/06/12

Cite this

Gregory, G. P., Arumugaswamy, A., Leung, T., Chan, K-L., Abikhair, M., David, K., Tam, C. S., Bajel, A., Cher, L., Grigg, A. P., Ritchie, D. S., & Opat, S. (2012). Immuno-chemotherapy containing rituximab is associated with improved survival in primary CNS B cell lymphoma. Poster session presented at 17th Congress of the European Hematology Association, Amsterdam, Netherlands.